113 related articles for article (PubMed ID: 9342718)
1. A staged protocol for the treatment of persistent pulmonary hypertension of the newborn.
Sasse S; Kribs A; Vierzig A; Roth B
Klin Padiatr; 1997; 209(5):301-7. PubMed ID: 9342718
[TBL] [Abstract][Full Text] [Related]
2. Comparison of high-frequency flow interruption ventilation and hyperventilation in persistent pulmonary hypertension of the newborn.
Jirapaet KS; Kiatchuskul P; Kolatat T; Srisuparb P
Respir Care; 2001 Jun; 46(6):586-94. PubMed ID: 11353547
[TBL] [Abstract][Full Text] [Related]
3. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome.
Kennaugh JM; Kinsella JP; Abman SH; Hernandez JA; Moreland SG; Rosenberg AA
J Perinatol; 1997; 17(5):366-9. PubMed ID: 9373841
[TBL] [Abstract][Full Text] [Related]
4. Histologic chorioamnionitis: an occult marker of severe pulmonary hypertension in the term newborn.
Woldesenbet M; Perlman JM
J Perinatol; 2005 Mar; 25(3):189-92. PubMed ID: 15592427
[TBL] [Abstract][Full Text] [Related]
5. High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure.
Carter JM; Gerstmann DR; Clark RH; Snyder G; Cornish JD; Null DM; deLemos RA
Pediatrics; 1990 Feb; 85(2):159-64. PubMed ID: 2296503
[TBL] [Abstract][Full Text] [Related]
6. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
Reynolds EW; Ellington JG; Vranicar M; Bada HS
Pediatrics; 2004 Nov; 114(5):1297-304. PubMed ID: 15520111
[TBL] [Abstract][Full Text] [Related]
7. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
[TBL] [Abstract][Full Text] [Related]
8. Neonatal pulmonary hypertension treated with inhaled nitric oxide and high-frequency ventilation.
Coates EW; Klinepeter ME; O'Shea TM
J Perinatol; 2008 Oct; 28(10):675-9. PubMed ID: 18580880
[TBL] [Abstract][Full Text] [Related]
9. Use of extracorporeal membrane oxygenators in persistent pulmonary hypertension of the newborn.
Andrews AF; Roloff DW; Bartlett RH
Clin Perinatol; 1984 Oct; 11(3):729-35. PubMed ID: 6488675
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal membrane oxygenation in the newborn and beyond.
Stork E
Clin Perinatol; 1988 Dec; 15(4):815-29. PubMed ID: 3061700
[TBL] [Abstract][Full Text] [Related]
11. Persistent pulmonary hypertension of the newborn with transposition of the great arteries.
Roofthooft MT; Bergman KA; Waterbolk TW; Ebels T; Bartelds B; Berger RM
Ann Thorac Surg; 2007 Apr; 83(4):1446-50. PubMed ID: 17383355
[TBL] [Abstract][Full Text] [Related]
12. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
[TBL] [Abstract][Full Text] [Related]
13. Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation.
Walsh-Sukys MC; Cornell DJ; Houston LN; Keszler M; Kanto WP
Pediatrics; 1994 Sep; 94(3):303-6. PubMed ID: 8065854
[TBL] [Abstract][Full Text] [Related]
14. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure.
Sills JH; Cvetnic WG; Pietz J
J Perinatol; 1989 Mar; 9(1):43-8. PubMed ID: 2651595
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.
Gupta A; Rastogi S; Sahni R; Bhutada A; Bateman D; Rastogi D; Smerling A; Wung JT
J Perinatol; 2002 Sep; 22(6):435-41. PubMed ID: 12168118
[TBL] [Abstract][Full Text] [Related]
16. Outcome of neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.
Chotigeat U; Khorana M; Kanjanapatakul W
J Med Assoc Thai; 2002 Jul; 85(7):800-7. PubMed ID: 12296412
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy.
Fakioglu H; Totapally BR; Torbati D; Raszynski A; Sussmane JB; Wolfsdorf J
J Crit Care; 2005 Sep; 20(3):288-93. PubMed ID: 16253800
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiologic principles relevant for therapeutic procedures in persistent pulmonary hypertension of the newborn.
Stopfkuchen H
Klin Padiatr; 1995; 207(2):63-7. PubMed ID: 7752602
[TBL] [Abstract][Full Text] [Related]
19. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation.
Dworetz AR; Moya FR; Sabo B; Gladstone I; Gross I
Pediatrics; 1989 Jul; 84(1):1-6. PubMed ID: 2740158
[TBL] [Abstract][Full Text] [Related]
20. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn.
Kumar P; Kazzi NJ; Shankaran S
Am J Perinatol; 1996 Aug; 13(6):335-41. PubMed ID: 8865978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
